These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2436113)

  • 41. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment.
    Braak H; Braak E; Ohm T; Bohl J
    Stain Technol; 1988 Jul; 63(4):197-200. PubMed ID: 2464205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hypothalamic lateral tuberal nucleus in Alzheimer's disease.
    Kremer B; Swaab D; Bots G; Fisser B; Ravid R; Roos R
    Ann Neurol; 1991 Mar; 29(3):279-84. PubMed ID: 1710433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.
    Heckers S; Geula C; Mesulam MM
    Neurobiol Aging; 1992; 13(4):455-60. PubMed ID: 1508295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease.
    Mann DM; Neary D; Yates PO; Lincoln J; Snowden JS; Stanworth P
    Neuropathol Appl Neurobiol; 1981; 7(1):37-47. PubMed ID: 7231636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alzheimer's disease and the cytoskeleton.
    Weber M
    Biochimie; 1986 Apr; 68(4):593-5. PubMed ID: 2427126
    [No Abstract]   [Full Text] [Related]  

  • 46. Organization of cerebral cortical afferent systems in the rat. II. Hypothalamocortical projections.
    Saper CB
    J Comp Neurol; 1985 Jul; 237(1):21-46. PubMed ID: 2995455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The site and nature of the primary lesions in Alzheimer's disease.
    Mann DM
    Prog Clin Biol Res; 1989; 317():303-11. PubMed ID: 2690105
    [No Abstract]   [Full Text] [Related]  

  • 48. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients.
    van de Nes JA; Kamphorst W; Ravid R; Swaab DF
    Brain; 1993 Feb; 116 ( Pt 1)():103-15. PubMed ID: 7680932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
    Geula C; Mesulam M
    Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions.
    Hammond P; Brimijoin S
    J Neurochem; 1988 Apr; 50(4):1111-6. PubMed ID: 2964509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.
    Ball MJ
    Acta Neuropathol; 1977 Feb; 37(2):111-8. PubMed ID: 848276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
    Dessi F; Colle MA; Hauw JJ; Duyckaerts C
    Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some enkephalin- or VIP-immunoreactive hippocampal pyramidal cells contain neurofibrillary tangles in the brains of aged humans and persons with Alzheimer's disease.
    Kulmala HK
    Neurochem Pathol; 1985; 3(1):41-51. PubMed ID: 2410823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
    Smith MA; Kutty RK; Richey PL; Yan SD; Stern D; Chader GJ; Wiggert B; Petersen RB; Perry G
    Am J Pathol; 1994 Jul; 145(1):42-7. PubMed ID: 8030754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's disease: does neuron plasticity predispose to axonal neurofibrillary degeneration?
    Ashford JW; Jarvik L
    N Engl J Med; 1985 Aug; 313(6):388-9. PubMed ID: 4010760
    [No Abstract]   [Full Text] [Related]  

  • 58. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
    Carson KA; Geula C; Mesulam MM
    Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei.
    Schultz C; Ghebremedhin E; Braak H; Braak E
    Acta Neuropathol; 1997 Jul; 94(1):99-102. PubMed ID: 9224538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical damage to rat cortical axons mimics early Alzheimer's neuronal pathology.
    King CE; Jacobs I; Dickson TC; Vickers JC
    Neuroreport; 1997 May; 8(7):1663-5. PubMed ID: 9189910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.